HighTower Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,621
| Closed | -$421K | – | 3548 |
|
|
2024
Q2 | $421K | Buy |
14,621
+110
| +0.8% | +$3.17K | ﹤0.01% | 2430 |
|
|
2024
Q1 | $424K | Buy |
14,511
+5,715
| +65% | +$167K | ﹤0.01% | 2380 |
|
|
2023
Q4 | $296K | Buy |
8,796
+865
| +11% | +$29.1K | ﹤0.01% | 2690 |
|
|
2023
Q3 | $242K | Buy |
+7,931
| New | +$242K | ﹤0.01% | 2752 |
|
|
2022
Q2 | – | Sell |
-34,201
| Closed | -$2.6M | – | 3128 |
|
|
2022
Q1 | $2.6M | Buy |
34,201
+30,812
| +909% | +$2.35M | 0.01% | 1224 |
|
|
2021
Q4 | $203K | Sell |
3,389
-157
| -4% | -$9.4K | ﹤0.01% | 2746 |
|
|
2021
Q3 | $200K | Buy |
3,546
+163
| +5% | +$9.19K | ﹤0.01% | 2700 |
|
|
2021
Q2 | $203K | Buy |
3,383
+9
| +0.3% | +$540 | ﹤0.01% | 2647 |
|
|
2021
Q1 | $238K | Hold |
3,374
| – | – | ﹤0.01% | 2456 |
|
|
2020
Q4 | $200K | Sell |
3,374
-1,000
| -23% | -$59.3K | ﹤0.01% | 2169 |
|
|
2020
Q3 | $260K | Buy |
4,374
+474
| +12% | +$28.2K | ﹤0.01% | 1893 |
|
|
2020
Q2 | $205K | Buy |
+3,900
| New | +$205K | ﹤0.01% | 1962 |
|
|
2019
Q1 | – | Sell |
-5,535
| Closed | -$237K | – | 2215 |
|
|
2018
Q4 | $237K | Sell |
5,535
-68
| -1% | -$2.91K | ﹤0.01% | 1729 |
|
|
2018
Q3 | $274K | Buy |
+5,603
| New | +$274K | ﹤0.01% | 1767 |
|
|
2018
Q1 | – | Sell |
-6,000
| Closed | -$275K | – | 2132 |
|
|
2017
Q4 | $275K | Hold |
6,000
| – | – | ﹤0.01% | 1739 |
|
|
2017
Q3 | $226K | Buy |
+6,000
| New | +$226K | ﹤0.01% | 1827 |
|
|
2016
Q2 | – | Sell |
-4,147
| Closed | -$219K | – | 1879 |
|
|
2016
Q1 | $219K | Sell |
4,147
-78
| -2% | -$4.12K | ﹤0.01% | 1696 |
|
|
2015
Q4 | $325K | Buy |
+4,225
| New | +$325K | ﹤0.01% | 1523 |
|